Just the facts my friend.....just the facts
Phase one and 2 were successful
Phase 2 showed twice the survival rate of endometrial cancer (EC) than the only available non-specific multi-billion dollar drug doxorubicin
Phase 3 successful 1st and 2nd DSMB reviews. The third and last one about 2 to 3 months from now
Phase 2 prostate cancer met end point recently
Macrilen Phase 3 results expected in November
Company has over $40 million in cash and no debt..
All the above equal to biggest deal in the stock market at these prices.
Warrant conversion will end and this puppy will fly
yeah....long and incoherent rumble with absoluyely no punctuation. This dude on steroids needs to get his GED
With FDA's special assessment it could go straight to market
You need to add successful Phase 2 ZoptEC for prostate cancer and Macrilen to your option 3
depends on the price and volume....I assumed the same factor given by the September 21 and September 24 news and extrapolated going forward.....not an exact science but a good approximation.
Remember that the CEO said there were over 24 million warrants on August 13 during the conference call...
Right now I see light at the end of the tunnel.......and it's approaching fast.
We all know that ZoptEC and Micrilen have potential of becoming blockbusters.......Once conversions end the stock will move up fast.....we want that and the warrant holders want that too
September 21 news ------ 10.8 million Series B Warrants remained outstanding
September 24 news ------- 8.2 million Series B Warrants remained outstanding
Extrapolate to EOD today and there will be approximately 5 million Series B outstanding warrants.
Bottom line 1: With no news AEZS will be trading between 8.5c and 9.5c........With any new it will go above 10c in a hurry and volume will accelerae warrnt conversion.
Bottom line 2: Warrant conversion will likely end by the end of next week,,,,after that the stock will find blue skies .
Bottom line 3: I expect DSMB news the week of October 5.....at that time conversion should be completed. Stock will be trading in the 20c+ area ahead of news.
Just for trying to get in at a fraction of a cent cheaper???
Thank you very much for the information
Thank you for posting
ZoptEC is a wondr drug
Short cut to market
AEZS is a true multi-bagger. Those not buying at these prices will kick their nuts or bite their titties when AEZS jumps to 50c++ after DSMB news in less than two weeks
Can you share your calcs for AEZS to 700 million shares after the cashless warrants are converted? TIA